Registry Study of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension in Poland
Led by Polish Cardiology Association · Updated on 2019-05-22
3000
Participants Needed
1
Research Sites
260 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are conducting a multicenter observational study called the BNP-PL Registry to track and understand the clinical progression and management of pulmonary hypertension in Poland. This study focuses on patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed by right heart catheterization. The initiative is led by the Polish Cardiac Society and involves accredited pulmonary hypertension centers across Poland, with data managed by Jagiellonian University Medical College.
The study collects patient information through an electronic platform without affecting their diagnosis or treatment. It includes patients of various ages, such as adults with pulmonary arterial hypertension, children with the same condition, and adults with chronic thromboembolic pulmonary hypertension. Data collection aims to describe current medical practices and patient outcomes related to these conditions.
Participants are followed over time, with mortality tracked from enrollment for at least five years. No personal data is entered into the database to protect privacy. The study does not involve any experimental treatments but gathers observational data to better understand these diseases and their management in routine care settings.
CONDITIONS
Brief Title
DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL
Research Team
G
Grzegorz Kopeć
M
Magdalena Studnicka
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients diagnosed with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension after March 1, 2018, who are older than 3 months at enrollment and meet specific blood pressure criteria
Patients diagnosed with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension before March 1, 2018, who are older than 3 months at enrollment and meet specific blood pressure criteria
You will not qualify if you...
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Long-term Monitoring
Duration - At least 5 years
Participants who undergo routine care are observed. Measurements are collected before and after routine healthcare to describe current practice and outcomes in pulmonary hypertension.
Visits as per routine clinical practice
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Using 129Xenon MRI and Spectroscopy to Monitor Response to Sotatercept Treatment in Adults with Pulmonary Arterial Hypertension
Using 129 Xenon MRI to Diagnose and Monitor Treatment in Pulmonary Arterial Hypertension
Including Idiopathic and Connective Tissue Disease-Associated Types
Study of 129Xe Gas Exchange MRI to Understand Lung and Heart Function in Adults
Long-term Study of Sotatercept Added to Standard Treatment for Pulmonary Arterial Hypertension
Pilot Study of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation Compared to Placebo in Adults With Pulmonary Arterial Hypertension
Observational Study of Healthy Pregnant Women at High Altitude and Sea Level in Bolivia
Tracking Heart and Baby Health During and After Pregnancy
Study of Empagliflozin for Treating Adults with Pulmonary Arterial Hypertension to Assess Effectiveness and Safety
Phase 3 Study of Once Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension
Phase 2 Open-Label Study of APL-9796 in Adults Aged 18 to 80 With Pulmonary Hypertension Using CardioMEMS PA Sensor
A Phase 3 Adaptive Study of IKT-001 Tablets to Treat Pulmonary Arterial Hypertension in Adults
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL).
Grzegorz Kopeć, Olga Dzikowska-Diduch, Ewa Mroczek...
Effects of β-Blockers on the Outcomes in Patients With Pulmonary Arterial Hypertension Stratified by the Presence of Comorbid Conditions: A Multicenter Prospective Cohort Study: The Database of Pulmonary Hypertension in the Polish Population (BNP-PL).
Marcin Waligóra, Marcin Kurzyna, Tatiana Mularek-Kubzdela...